Table 1.
Baseline characteristics of the eligible minimally invasive surgical therapies
| Study [reference]/location | Number randomized | Duration (mo) | Mean age | Mean IPSS | Mean prostate volume (ml) |
|---|---|---|---|---|---|
| Prostatic arterial embolization versus TURP | |||||
| Abt (2018) [10]/Switzerland | 103 | 3 | 66 | 18 | 52 |
| Carnevale (2016) [11]/Brazil | 30 | 12 | 65 | 26 | 60 |
| Gao (2014) [12]/China | 114 | 24 | 67 | 23 | 64 |
| Totals and means | 247 | 66 | 21 | 58 | |
| Prostatic urethral lift versus TURP | |||||
| Gratzke (2017) [7]/Europe | 91 | 24 | 64 | 22 | 39 |
| Prostatic urethral lift versus sham | |||||
| Roehrborn (2013) [6]/USA, Canada, Australia | 206 | 3 | 66 | 23 | 43 |
| Transurethral prostate convective radiofrequency water vapor (Rezūm system) versus sham | |||||
| McVary (2016) [15]/USA | 197 | 3 | 63 | 22 | 45 |
| Aquablation versus TURP | |||||
| Gilling (2019) [14]/International | 184 | 12 | 66 | 23 | 53 |
IPSS = International Prostate Symptom Score; TURP = transurethral prostate resection.